Pharmafile Logo
Pharmafocus logo
Advanced Search

India

Showing 15 posts of 141 posts found.

Teva image

Teva moves to buy Mylan

April 21, 2015
Research and Development, Sales and Marketing India, Mylan, Perrigo, Teva, US, Vigodman, generics, israel, merger

Israeli generics drug giant Teva has made an offer to buy its US rival Mylan for around $40.1 billion. The …

News
Daiichi image

Daiichi Sankyo to sell Sun Pharma stake

April 21, 2015
Manufacturing and Production, Sales and Marketing Daiichi Sankyo, FDA, India, Ranbaxy, Sun Pharma, generics

Daiichi Sankyo is to sell off all or part of its stake in Sun Pharma and back away from the …

News
Sun Pharmaceutical Industries, India

Sun Pharma completes Ranbaxy acquisition

March 26, 2015
Manufacturing and Production, Sales and Marketing Daiichi Sankyo, India, Ranbaxy, Sun Pharma, cci

Sun Pharma has closed its mega merger deal with Ranbaxy and begun the integration of the two businesses. The combined …

News
Mylan image

Mylan buys into women’s health

February 3, 2015
Sales and Marketing Abbott, FDA, India, Mylan, famy care, female, women

Mylan is to acquire a number of women’s healthcare companies from Indian-based Famy Care that will build upon its 2008 …

News

Sun Pharma and Ranbaxy merger gets US nod

February 2, 2015
Manufacturing and Production, Sales and Marketing India, Ranbaxy, Sun Pharma, US, generics, merger, recall, torrent

The US Federal Trade Commission has given its approval for Sun Pharma’s $4 billion acquisition of troubled Indian firm Ranbaxy …

News

Humira biosimilar released in India

December 18, 2014
Research and Development, Sales and Marketing Humira, India, Zydus Cadila, anti-inflammatory, arthritis, bioscience

Indian firm Zydus Cadila has launched the first biosimilar of AbbVie’s anti-inflammatory medicine Humira, the world’s biggest-selling drug. Used as …

News
Ranbaxy image

Ranbaxy launches J&J biosimilar in India

December 5, 2014
Manufacturing and Production, Sales and Marketing CHMP, FDA, India, J&J, JJ, Ranbaxy, Remicade, nlem, nppa

Ranbaxy has launched the first biosimilar of Johnson & Johnson’s Remicade (infliximab) in India, marking the firm’s entry into monoclonal …

News

India ‘likely’ to increase price caps

June 25, 2014
Manufacturing and Production, Sales and Marketing China, FDA, India, UK, pricing

India’s government is ‘likely’ to increase the number of drugs which are subject to price caps, according to a report …

News
Dr Reddy's image

Dr Reddy’s recalls blood pressure drug

June 20, 2014
Manufacturing and Production Dr Reddy's, India, blood pressure, metoprolol succinate, recall, toprol

Indian generics manufacturer Dr Reddy’s Laboratories is in the midst of recalling more than 13,000 bottles of blood pressure medicine …

News
Novartis logo

Novartis agrees Gleevec patent deal

May 19, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Gleevec, India, Novartis, Sun Pharma, patent

Novartis has settled patent litigation with Sun Pharmaceutical Industries in the US, paving the way for the Indian company’s subsidiary …

News
Ranbaxy

Regulatory woes eclipse Sun Pharma deal

April 10, 2014
Manufacturing and Production, Sales and Marketing FDA, India, Ranbaxy, Sun Pharma

The $4 billion merger between Indian generic firms Sun Pharma and Ranbaxy has been soured by reports that the deal …

News
GSK image

GSK increases India stake

March 11, 2014
Manufacturing and Production, Sales and Marketing FDA, GSK, India, Nashik, OTC, Thane, bangalore

GlaxoSmithKline has taken a further step into the Indian pharma market by increasing its stake in its subsidiary company there, …

News

FDA: India needs more inspectors

February 25, 2014
Manufacturing and Production FDA, India, generics, hamburg

The Food and Drug Administration is to put more inspectors on the ground in India, following a visit there by …

News
herceptin_roche_cancer

India court grants Herceptin injunction

February 10, 2014
Research and Development, Sales and Marketing Biocon, Herceptin, India, Mylan, Roche

Roche has been granted an injunction by a court in India to prevent generic manufacturers of its ageing breast cancer …

News
Sovaldi image

Gilead to allow cheaper generics of new hep C drug

February 6, 2014
Manufacturing and Production, Sales and Marketing Gilead, India, generics, hep C, s&m, sofosbuvir, sovaldi

Gilead has announced the unusual step of allowing its new and highly expensive hepatitis C pill to be sold as …

News

Latest content

AstraZeneca’s Imfinzi approved in US for endometrial cancer treatment

June 17, 2024

Innate Pharma shares results from phase 1/2 trial for blood cancer treatment

June 17, 2024

CytoSorbents announces EU launch and availability of PuriFi blood pump

June 14, 2024

AbbVie and FutureGen announce license agreement for IBD therapy

June 14, 2024

Pfizer shares update on DMD gene therapy clinical trial

June 13, 2024